RecruitingNCT05958706

Mitochondrial Substrate Utilization in the Diabetic Human Heart


Sponsor

Heinrich-Heine University, Duesseldorf

Enrollment

500 participants

Start Date

Dec 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Diabetes can lead to heart failure independently, but the underlying causes remain incompletely understood. The main aim of this study is to identify differential regulation of mitochondrial substrate utilization and complex activity in heart failure and type 2 diabetes mellitus (T2DM). For this, we will conduct a prospective, observational study to examine myocardial mitochondrial oxidative function and related metabolic parameters, gene expression, histological markers, and inflammation in cardiac tissue from patients with heart failure or patients after heart transplantation. We will further assess cardiac function using cardiac magnetic resonance imaging with and without stress protocols and magnetic resonance spectroscopy. Glycemic control/T2DM will be characterized by oral glucose tolerance tests. The results of this project will help to better understand the cellular mechanisms of the development of diabetic cardiomyopathy and contribute to the development of early diagnostic, as well as therapeutic approaches for the prevention and treatment of diabetic cardiomyopathy.


Eligibility

Min Age: 20 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how the heart muscle uses different energy sources (fats, sugars) in people with heart failure, with or without Type 2 diabetes. Researchers will analyze small heart muscle tissue samples taken during already-planned heart procedures to understand how diabetes changes heart energy metabolism. **You may be eligible if...** - You are 20 to 85 years old - You have heart failure (NYHA Class II–IV or end-stage heart failure) and are already having a heart biopsy or have had a heart transplant requiring a biopsy - You may or may not have Type 2 diabetes **You may NOT be eligible if...** - You have had an acute infection in the past 2 weeks - You have an active autoimmune disease or severely suppressed immune system - You are pregnant - You have HIV, hepatitis B or C, or active liver disease (unrelated to heart failure) - You have active cancer - You are unable or unwilling to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine

Düsseldorf, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05958706


Related Trials